4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-030329
President, CEO, and Chairman acquired 750,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2020-11-03 | Conversion | +750,000 | 5,925,000 | I | ||
| Derivatives | |||||||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2020-11-03 | Conversion · Series A Convertible Preferred Stock | −750,000 | 0 | I | ||
Loading xslF345X03/doc4.xml…